Astodrimer

DB11854InvestigationalProtein Based Therapies

Astodrimer has been used in trials studying the treatment and prevention of Bacterial Vaginosis. It is a lysine-based dendrimer with naphthalene disulfonic acid surface groups.

Mechanism
Curator reviewed
Also known as
Vivagel
Code names
BRI-7013 · SPL-7013

Resolves to

Targets

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Astodrimer, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account